Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Acrivon Therapeutics, Inc. | Chief Accounting Officer | Common Stock | 4.54K | $35.9K | $7.92 | Nov 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACRV | Acrivon Therapeutics, Inc. | Nov 14, 2024 | 1 | -$784 | 4 | Nov 18, 2024 | Chief Accounting Officer |
ACRV | Acrivon Therapeutics, Inc. | Aug 14, 2024 | 1 | -$695 | 4 | Aug 16, 2024 | Chief Accounting Officer |
ACRV | Acrivon Therapeutics, Inc. | May 14, 2024 | 1 | -$828 | 4 | May 16, 2024 | Chief Accounting Officer |
ACRV | Acrivon Therapeutics, Inc. | May 13, 2024 | 0 | $0 | 3 | May 16, 2024 | Chief Accounting Officer |